As of 2026-09-19, the Relative Valuation of Mirati Therapeutics Inc (MRTX) is (264.38) USD. This relative valuation is based on P/E multiples. With the latest stock price at 58.70 USD, the upside of Mirati Therapeutics Inc based on Relative Valuation is -550.4%.
The range of the Relative Valuation is (254.34) - (275.24) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.5x - 26.6x | 23.8x |
| Forward P/E multiples | 24.6x - 27.6x | 27.3x |
| Fair Price | (254.34) - (275.24) | (264.38) |
| Upside | -533.3% - -568.9% | -550.4% |
| Date | P/E |